http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103463067-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-438 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
| filingDate | 2013-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103463067-B |
| titleOfInvention | The application of Lycojaponicumin C in preparation treatment flavivirus infections medicine |
| abstract | Do you the invention discloses a kind of Lycojaponicumin? the application of C in preparation treatment or prevention flavivirus infections medicine.Lycojaponicumin? C can suppress the propagation of yellow fever virus effectively, but very little to cytotoxicity, can be developed as the medicine of the disease that these viral infection for the treatment of cause further, be with a wide range of applications.The Lycojaponicumin that the present invention relates to? the purposes of C in preparation treatment flavivirus infections medicine belongs to first public, because framework types belongs to brand-new framework types, and it is unexpectedly strong for yellow fever virus inhibit activities, there is not the possibility being provided any enlightenment by other compounds, possess outstanding substantive distinguishing features, the control simultaneously for flavivirus infections obviously has significant progress. |
| priorityDate | 2013-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.